Here’s what you should know:
1. Blautix completed a phase I trial last year, showing it was both safe and well tolerated by patients.
2. 4D Pharma researchers said their research claims the microbiome causes or exacerbates IBS.
3. Blautix uses live bacteria to treat irritable bowel syndrome by reacting with bacteria present in the microbiome.
More articles on gastroenterology:
GI leader to know: Dr. Erick Singh of Consultants in Gastroenterology
‘Relentless dedication to IBD care’ — How 3 GI leaders will use their Sherman Prizes to enhance IBD, Crohn’s treatment
Creo Medical’s device receives FDA 510(k) approval & more — 6 GI company key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
